[促性腺激素释放激素（LH-RH）类似物治疗下前列腺癌患者生活质量（QOL）的评估]
[Assessment of the quality of life (QOL) of prostatic cancer patients under LH-RH analogue treatment].
作者信息
Ueda S, Nishi K, Yoshida M
机构信息
Department of Urology, Kumamoto University School of Medicine.
出版信息
Nihon Rinsho. 1998 Aug;56(8):2119-23.
Assessments of QOL on 53 prostatic cancer patients under LH-RH analogue treatment were evaluated using our own questionnaire. Three months after treatment, the improvement of ADL, appetite, physical symptoms, mental symptoms, sexual life and social life occurred in 24.3%, 51.5%, 44.7%, 29.7%, 7.5% and 35.4% of the patients, respectively. Twelve months after treatment, the improvement of them occurred in 30.9%, 48.4%, 31.7%, 33.7%, 8.3% and 34.4%, respectively. The quality of sexual life for the prostatic cancer patients treated with LH-RH analogue was worse than that of others. LH-RH analogue is effective on QOL in the treatment of prostatic cancer patients.
使用我们自己的调查问卷对53例接受促性腺激素释放激素（LH-RH）类似物治疗的前列腺癌患者的生活质量进行了评估。治疗三个月后，日常生活活动能力（ADL）、食欲、身体症状、精神症状、性生活和社交生活改善的患者分别占24.3%、51.5%、44.7%、29.7%、7.5%和35.4%。治疗十二个月后，上述各项改善的患者分别占30.9%、48.4%、31.7%、33.7%、8.3%和34.4%。接受LH-RH类似物治疗的前列腺癌患者的性生活质量比其他患者差。LH-RH类似物在治疗前列腺癌患者时对生活质量有效。
Zotero 插件